Ipf Incidence And Prevalence 2024 Worldwide. Prevalence of ssc ild and ra ild ranged from 26.1% to 88.1% and 0.6% to 63.7%, respectively. In europe and north america, estimated ipf prevalence rates range from 0.33 to 2.51 and 2.40 to 2.98 per 10,000 people, respectively.
This review highlights the current landscape of ipf research in the development of novel compounds for the treatment of ipf while also evaluating. Describe prevalence and characteristics of patients with newly diagnosed.
